FLT1 and chronic kidney disease: There was no significant difference in the medians of the biomarkers between the diabetic and non-diabetic CKD patients for angiopoietin-1, VEGF-A, angiopoietin-1/VEGF-A ratio, VEGFR-1, VEGFR-2, or pentraxin-3.